Register for our free email digests:
Latest From Biotica Technology Ltd.
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced August-September 2014.
Dr Edward Hodgkin
Derived from Strategic Transactions, Elsevier Business Intelligence’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment –In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type –Acquisition, Alliance, or Financing.
Dr Alan Lewis has jointed Biotica Technology (UK) as a non-executive director. He is president and CEO of the Juvenile Diabetes Research Foundation (JDRF). Before joining the JDRF in January, Dr Lewis was CEO of the San Diego-based biotechnology company Novocell.
- Implantable Devices
Surgical Equipment & Devices
- Minimally or Less Invasive
- Therapeutic Areas
- Western Europe
- Parent & Subsidiaries
- Adoptics AG
- Senior Management
- Khalid Mentak, CEO
- Contact Info
Phone: (41) 925353
Bruggin Biel, 2555
You must sign in to use this functionality
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.